Roger Crossley

1.6k total citations
33 papers, 1.2k citations indexed

About

Roger Crossley is a scholar working on Organic Chemistry, Molecular Biology and Gastroenterology. According to data from OpenAlex, Roger Crossley has authored 33 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 7 papers in Molecular Biology and 5 papers in Gastroenterology. Recurrent topics in Roger Crossley's work include Synthesis and Characterization of Heterocyclic Compounds (4 papers), Gastrointestinal motility and disorders (4 papers) and Synthesis of heterocyclic compounds (4 papers). Roger Crossley is often cited by papers focused on Synthesis and Characterization of Heterocyclic Compounds (4 papers), Gastrointestinal motility and disorders (4 papers) and Synthesis of heterocyclic compounds (4 papers). Roger Crossley collaborates with scholars based in United States, United Kingdom and Denmark. Roger Crossley's co-authors include Gary Colquhoun, R. W. Baines, Peter G. Sammes, Charles E. Pope, Douglas L. Brand, Sidney Cohen, Washington Finkelstein, Donald O. Castell, Charles S. Winans and José Behar and has published in prestigious journals such as The Lancet, Gastroenterology and The Journal of Physiology.

In The Last Decade

Roger Crossley

30 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roger Crossley United States 17 354 259 199 194 170 33 1.2k
David M. Parry Canada 22 250 0.7× 83 0.3× 409 2.1× 554 2.9× 37 0.2× 57 1.6k
Katsumi Yamamoto Japan 18 672 1.9× 235 0.9× 250 1.3× 174 0.9× 40 0.2× 194 1.8k
Takaaki Goto Japan 20 178 0.5× 36 0.1× 138 0.7× 509 2.6× 95 0.6× 78 1.5k
Roland Heinig Germany 17 106 0.3× 66 0.3× 51 0.3× 357 1.8× 76 0.4× 57 1.3k
Shunsuke Watanabe Japan 24 208 0.6× 65 0.3× 69 0.3× 223 1.1× 16 0.1× 139 1.5k
Avik Sarkar United States 22 312 0.9× 29 0.1× 119 0.6× 325 1.7× 621 3.7× 109 1.5k
Junqing Chen China 24 247 0.7× 155 0.6× 412 2.1× 1.0k 5.3× 76 0.4× 133 2.3k
Weiming Kang China 23 505 1.4× 220 0.8× 326 1.6× 497 2.6× 10 0.1× 127 1.9k
Takenori Takahata Japan 19 151 0.4× 50 0.2× 56 0.3× 477 2.5× 62 0.4× 50 1.3k
Joanne M. Donovan United States 22 821 2.3× 27 0.1× 98 0.5× 564 2.9× 44 0.3× 48 1.7k

Countries citing papers authored by Roger Crossley

Since Specialization
Citations

This map shows the geographic impact of Roger Crossley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Crossley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Crossley more than expected).

Fields of papers citing papers by Roger Crossley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Crossley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Crossley. The network helps show where Roger Crossley may publish in the future.

Co-authorship network of co-authors of Roger Crossley

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Crossley. A scholar is included among the top collaborators of Roger Crossley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Crossley. Roger Crossley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flood, Robert G., Jason F. Talbott, David Minks, et al.. (2024). Initial experience using middle meningeal artery embolisation for patients with recurrent and high-recurrence-risk chronic subdural haematoma. Journal of Clinical Neuroscience. 125. 126–131. 3 indexed citations
2.
Crossley, Roger, et al.. (2011). Thematic Analysis™ : A Chemogenomic Approach to GPCR Drug Discovery. Current Topics in Medicinal Chemistry. 11(15). 1925–1943. 3 indexed citations
3.
Crossley, Roger. (2004). The Design of Screening Libraries Targeted at G-Protein Coupled Receptors. Current Topics in Medicinal Chemistry. 4(6). 581–589. 17 indexed citations
4.
Crossley, Roger. (2003). GPCRs come of age in San Diego. Drug Discovery Today. 8(1). 19–20. 1 indexed citations
5.
Calhoun, William J., et al.. (1995). Synthesis and Antiinflammatory Activity of Certain 5,6,7,8-Tetrahydroquinolines and Related Compounds. Journal of Medicinal Chemistry. 38(9). 1473–1481. 29 indexed citations
6.
Crossley, Roger, et al.. (1994). Synthesis and properties of a potential extracellular fluorescent probe for potassium. Journal of the Chemical Society Perkin Transactions 2. 1615–1615. 54 indexed citations
7.
Colquhoun, Gary, R. W. Baines, & Roger Crossley. (1993). A state of the art review of IDEFO. International Journal of Computer Integrated Manufacturing. 6(4). 252–264. 118 indexed citations
8.
Presant, Cary A., Douglas W. Blayney, Peter G. E. Kennedy, et al.. (1990). Preliminary report: imaging of Kaposi sarcoma and lymphoma in AIDS with indium-111-labelled liposomes. The Lancet. 335(8701). 1307–1309. 58 indexed citations
9.
Presant, Cary A., et al.. (1990). 111In-Labeled Liposomes for Tumor Imaging: Clinical Results of the International Liposome Imaging Study. Journal of Liposome Research. 1(4). 431–436. 8 indexed citations
10.
Presant, Cary A., Richard T. Proffitt, Alison Turner, et al.. (1988). Successful imaging of human cancer with indium-111-labeled phospholipid vesicles. Cancer. 62(5). 905–911. 69 indexed citations
11.
Crossley, Roger. (1983). Clinical safety and tolerance of mitoxantrone (Novantrone). Cancer Treatment Reviews. 10. 29–36. 17 indexed citations
12.
Crossley, Roger. (1983). Side effect and safety data for fenbufen. The American Journal of Medicine. 75(4). 84–90. 3 indexed citations
13.
Crossley, Roger. (1982). Project Planning, Investigator Selection, Data Harmonization. Drug Information Journal. 16(1-2). 35–43.
14.
Crossley, Roger, et al.. (1979). ChemInform Abstract: GASTRIC ANTISECRETORY ACTIVITY OF A SERIES OF 4‐ACYLAMINOTHIAZOLES. Chemischer Informationsdienst. 10(38). 1 indexed citations
15.
Englert, E., James W. Freston, David Y. Graham, et al.. (1978). Cimetidine, antacid, and hospitalization in the treatment of benign gastric ulcer. Gastroenterology. 74(2). 416–425. 65 indexed citations
16.
Behar, José, Douglas L. Brand, Donald O. Castell, et al.. (1978). Cimetidine in the treatment of symptomatic gastroesophageal reflux. Gastroenterology. 74(2). 441–448. 158 indexed citations
17.
Crossley, Roger, et al.. (1977). 5,6,7,8-Tetrahydroquinolines. 5. Antiulcer and antisecretory activity of 5,6,7,8-tetrahydroquinolinethioureas and related heterocycles. Journal of Medicinal Chemistry. 20(5). 718–721. 13 indexed citations
18.
Crossley, Roger, et al.. (1976). 5,6,7,8-Tetrahydroquinolines. Part II. Preparation and reactions of substituted 5,6,7,8-tetrahydroquinoline-8-carboxylic esters. Journal of the Chemical Society Perkin Transactions 1. 977–977. 3 indexed citations
19.
Crossley, Roger, et al.. (1974). A novel synthesis of thiols from α-amino-nitriles. Journal of the Chemical Society Perkin Transactions 1. 2327–2330. 1 indexed citations
20.
Crossley, Roger, et al.. (1972). Effect of controlled elevation of body temperature on human tolerance to +G z acceleration.. Journal of Applied Physiology. 33(4). 418–420. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026